Search for a funded project
Development of Succinate-based analogues and formulations against SARS-CoV-2 and influenza viruses-induced respiratory infections – SuccesS
viruses is a major concern. Those viruses include coronaviruses such as SARS-CoV-2 and influenza A viruses (IAV) [...] There are currently no efficient drugs against coronaviruses and the efficacy of anti-IAV drugs is disputed [...] impairs vaccine protection. Besides, previous coronaviruses crises showed that poorly neutralizing antibodies
Autoantibodies against type I IFNs in Lebanese patients hospitalized with COVID-19. – AAILC
Since 2003, three coronaviruses, SARS, MERS, and SARS-CoV-2, have led to devastating pandemics. Although [...] vaccines are available, new variants and even new coronaviruses could emerge at any time. Understanding the
Identification of early biomarkers of the response to corticosteroid therapy in COVID-19 patients. – CortiCoV
SARS-CoV-2 is the human coronavirus that caused the pandemic that began in Wuhan, China at the end of
Comprehension of MAIT cell functions during COVID-19 – COMAIT-19
response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the lung can lead to life-
Involvement of circulating fibrocytes in pathophysiology and prognosis of COVID-19 pneumonia – FIBROCO
High circulating levels of fibrocytes are correlated to an unfavourable outcome during acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis. COVID-19 pneumonia shares common histological and inflammatory features with ARDS. We aimed to determine the involvement of circulating fibrocytes during the course of COVID-19 pneumonia, and to assess if fibrocytes could be a prognosis biomarker.
Characterization of the microVAScular dysfunction in COvid-19 ARDS. – VASCO
Endothelial damage and coagulation activation at the lung microvascular level may play an important role in the physiopathology of the COVID-19 ARDS. The project aims to prospectively investigate both bedside pulmonary physiological markers (mainly alveolar dead-space) and biological markers of coagulopathy and endothelial dysfunction in COVID-19 and non-COVID-19 ARDS patients.
Early identification of risk associated with drugs used in COVID-19: analysis of global pharmacovigilance data – Vigi-Drugs COVID-19
Early Identification of Drug Risk in COVID-19: Analysis of Global Pharmacovigilance Data
Coronavirus Diagnostic combined with seasonal Flu Sensing – CorDial-FLU
Worldwide, infections and death from SARS-CoV-2 continue despite lockdown and the use of masks. What started as a temporary sanitary issue, has morphed into a more permanent and long-lasting pan epide
CK2 inhibitors as chemobiological tools to unravel CK2 role in SARS-COV-2 lifecycle and as potential antivirals with broad-anti-coronavirus activity – CK2COV
rum antiviral activity against other human coronaviruses (HCoV-229E, OC43, NL63 and HKU1).